Peking University
Clinical trials sponsored by Peking University, explained in plain language.
-
Texts, videos, or AI chat: which boosts Teens' health best?
Disease control Not yet recruitingThis study will test if digital health tools like text messages, videos, or an AI chat program can improve the physical and mental health of middle school students aged 11 to 13. About 800 students with normal weight, overweight, or obesity will be split into four groups to compa…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
New cancer drug SIG001 enters first human tests
Disease control Not yet recruitingThis early-phase study tests a new drug called SIG001 in 66 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose for future studies, and see if it can shrink tumors. Participants receiv…
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated May 26, 2026 07:08 UTC
-
AI coach and doctor team up to tackle diabetes in china
Disease control Not yet recruitingThis study tests a new approach for managing type 2 diabetes. 1,200 adults will use a smartphone app that gives feedback on their diet photos, plus get support from their family doctor. The goal is to see if this AI-powered program helps lower blood sugar levels better than stand…
Phase: NA • Sponsor: Peking University • Aim: Disease control
Last updated May 26, 2026 07:06 UTC
-
New combo therapy aims to control advanced liver cancer with vessel invasion
Disease control Not yet recruitingThis study tests whether adding a liver-directed chemotherapy infusion (HAIC) to a two-drug combination (lenvatinib and a PD-1 inhibitor) works better than the two drugs alone for people with advanced liver cancer that has invaded major blood vessels or bile ducts. About 150 adul…
Sponsor: Peking University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New hope for stomach cancer patients: experimental drug combo enters human trials
Disease control Not yet recruitingThis early-stage study tests the safety of a new drug called PX, given directly into the abdomen along with a standard chemotherapy (nab-paclitaxel), in 22 adults with a type of advanced abdominal cancer. The main goal is to find the safest dose and watch for side effects. This i…
Phase: PHASE1 • Sponsor: Peking University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Digital platform aims to curb childhood obesity in beijing schools
Prevention Not yet recruitingThis study tests if a school-based program using a WeChat platform can help prevent excessive weight gain in children aged 7-10 in Beijing. About 1,400 kids will take part, with half receiving health lessons, more physical activity, and parent support via the app. The goal is to …
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated May 26, 2026 07:14 UTC
-
Smartphone tool aims to stop pregnancy diabetes before it starts
Prevention Not yet recruitingThis study tests a digital health program that uses a risk prediction model to identify pregnant women at high risk for gestational diabetes early in pregnancy. Participants will receive online education, personalized lifestyle advice, and self-management tools through a digital …
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated May 20, 2026 11:56 UTC
-
Salt switch could shield Moms-to-Be from dangerous hypertension
Prevention Not yet recruitingThis study tests whether using low-sodium salt instead of regular salt can lower blood pressure and prevent pregnancy-related high blood pressure disorders in women at high risk. About 3,200 pregnant women in China will be randomly assigned to use either low-sodium or regular sal…
Phase: NA • Sponsor: Peking University • Aim: Prevention
Last updated May 11, 2026 20:52 UTC
-
New study aims to personalize depression treatment
Symptom relief Not yet recruitingThis study looks at how well the antidepressant escitalopram works in 200 adults who are having their first episode of major depression and have never taken medication for it. Participants will take escitalopram for 8 weeks, and researchers will track their symptoms, thinking ski…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated May 26, 2026 07:13 UTC
-
Brain training doses tested for memory loss
Symptom relief Not yet recruitingThis study looks at whether different amounts of computer-based brain training can improve thinking and memory in older adults with mild cognitive impairment (MCI). About 234 people aged 60 and older will do brain exercises at home for 12 weeks, with some doing more sessions than…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated May 26, 2026 07:07 UTC
-
AI writing therapy shows promise for grieving teens
Symptom relief Not yet recruitingThis study tests whether an AI-assisted writing program can help Chinese teenagers (ages 10-19) who are struggling with grief after losing a loved one. Participants will be split into three groups: one using AI-guided writing, one using writing without feedback, and one doing fre…
Phase: NA • Sponsor: Peking University • Aim: Symptom relief
Last updated May 19, 2026 11:48 UTC